Costs of Treating Bleeding and Perforated Peptic Ulcers in The Netherlands

Journal of Rheumatology

Volumn 31, Issue 4, 2004, Pages 788-791

  De Leest, Helena T J I ^a,b   Van Dieten, Hiske E M ^a   Van Tulder, Maurits W ^a   Lems, Willem F ^a   Dijkmans, Ben A C ^a   Boers, Maarten ^a  

^a Department of Rheumatology ^*

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cost analysis; Costs; Peptic ulcer hemorrhage; Peptic ulcer perforation

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DUODENUM BLEEDING; DUODENUM ULCER; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PARTIAL GASTRECTOMY; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; STOMACH HEMORRHAGE; STOMACH ULCER; ULCER PERFORATION;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; COSTS AND COST ANALYSIS; HEALTH CARE COSTS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NETHERLANDS; PEPTIC ULCER HEMORRHAGE; PEPTIC ULCER PERFORATION; RETROSPECTIVE STUDIES;

EID: 1842425825     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Wallace AJ. NSAID gastroenteropathy: current therapy and diagnosis. Drugs of Today 1997;33:115-22.
2. Lanza FL. Gastrointestinal toxicity of newer NSAIDs. Am J Gastroenterol 1993;88:1318-23.
3. Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000;343:1520-8.
4. Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000;284:1247-55.
5. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999;340:1888-99.
6. Chung SC. Peptic ulcer bleeding. Am J Gastroenterol 2001;96:1-3.
7. Lee FY, Leung KL, Lai BS, Ng SS, Dexter S, Lau WY. Predicting mortality and morbidity of patients operated on for perforated peptic ulcers. Arch Surg 2001;136:90-4.
8. Chevat C, Pena BM, Al MJ, Rutten FF. Healthcare resource utilisation and costs of treating NSAID-associated gastrointestinal toxicity. A multinational perspective. Pharmacoeconomics 2001;19 Suppl 1:17-32.
9. Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med 1998;105:31S-8S.
10. Singh G, Rosen RD. NSAID induced gastrointestinal complications: the ARAMIS perspective - 1997. Arthritis, Rheumatism, and Aging Medical Information System. J Rheumatol 1998;51 Suppl:8-16.
11. Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol 1999;26 Suppl 56:18-24.